Current clinical routine using serum PSA level and pre-surgery Gleason sum score to identify advanced disease remains inadequate, as the majority of screening detected PCa have PSA levels between 4–10 ng/ml and moderate Gleason sum scores of 6 and 7. Here, KLK3 is linked to posterior cortical atrophy.